Related Experiment Video
Updated: Jul 9, 2026

Field Identification of Matricaria chamomilla using a Portable qPCR System
Published on: October 10, 2020
The professionalization of Western herbalists: response to new product regulations in Canada
Karen Moss1, Heather Boon, Peri Ballantyne
1St. Michael's Hospital, 30 Bond Street, Toronto, Ont., M5B 1W8 Canada.
Abstract:
New Canadian Natural Health Products regulations (NHP regulations) came into law January 1st, 2004 and will be implemented over 6 years. These regulations have the potential to impact a variety of stakeholders, in particular complementary and alternative medicine (CAM) practitioners. In this article, we document Canadian Western herbalist leaders' responses to the new regulations, so as to provide insight into how new healthcare policy serves as a stimulus for the organization of an emerging healthcare profession. The data are derived from key informant interviews with Western herbalist leaders in Canada (n=9). The NHP regulations include "good manufacturing practices" and Western herbalist leaders are concerned that many small companies, often owned and run by Western herbalists, will find the regulations too costly to implement, causing them to reduce the number and diversity of products they manufacture, or go out of business all together. Furthermore, lack of availability of whole plant products could severely restrict the practice of Canadian Western herbalists. In response to this challenge, herbalists are attempting to (i) organize as a more cohesive group, (ii) define their unique body of knowledge and (iii) increase the perceived legitimacy of their practices in the eyes of the public, conventional healthcare practitioners, and regulators, in an attempt to protect their unique practices. An examination of the findings reveals the extent to which external factors (i.e., the new NHP regulations) both provoke and shape the professionalization of this group of healthcare practitioners.
Related Concept Videos
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Dosage Regimen: Individualization
Drug Classes and Categories
